Antisoma's AS1413 gains FDA Fast Track status for treatment of secondary acute myeloid leukaemia
04-Jun-2010
- United Kingdom
Most read news
Topics
Organizations
Antisoma
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.